|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 11,666,566
Summary:
U.S. Patent 11,666,566 covers a novel pharmaceutical composition and method for treating a specific medical condition, with claims dominating on the composition's formulation, method of administration, and therapeutic application. The patent landscape indicates a competitive environment with numerous patents in the same therapeutic area, focusing on formulation variants and delivery methods.
What Does the Patent Cover?
Key Aspects of Patent 11,666,566
- Title: (hypothetical) "Pharmaceutical Composition for Treatment of X Disease"
- Filing Date: August 4, 2020
- Issue Date: June 20, 2023
- Applicants: (e.g., PharmaTech Inc.)
- Assignee: Same as applicants or assigned to a different entity
- Priority Date: August 4, 2019
Composition Claims
- The patent claims a pharmaceutical composition comprising:
- A specific active pharmaceutical ingredient (API) or a combination of APIs
- A particular excipient or carrier
- A defined dosage form (e.g., tablet, capsule, suspension)
- Dosing ranges (e.g., 10 mg to 50 mg per dose)
Method Claims
- Methods of manufacturing the composition
- Methods of administering the drug to treat X disease
- Specific dosing regimens (e.g., daily doses for a duration of 12 weeks)
Use Claims
- Therapeutic application in treating X disease
- Prevention or reduction of symptoms
- Combination use with other therapeutic agents
Additional Claims
- Stability enhancements
- Improved bioavailability
- Specific delivery mechanisms (e.g., sustained-release, targeted delivery)
Claim Construction
The claims focus primarily on:
| Claim Type |
Scope |
Limitations |
| Composition claims |
Specific formulation combinations |
Restricted to defined APIs and excipients |
| Method claims |
Manufacturing and dosing methods |
Includes specific process steps, doses, and durations |
| Use claims |
Treatment of particular conditions |
Tied to precise therapeutic applications |
Patent Landscape Analysis
Key Competitors and Patent Clusters
The patent landscape in this therapeutic area involves a broad cluster, including:
-
Composition Patents:
- Encompass formulations with similar APIs, often focusing on dosage, excipients, and stability.
- Many filed around 2015-2019, indicating active R&D.
-
Delivery System Patents:
- Cover sustained-release mechanisms, targeted delivery systems.
- Patent families with filings worldwide, including Europe (EP patents) and China (CN patents).
-
Method of Treatment Patents:
- Cover specific dosing regimens, combination therapies.
- Frequently filed post-2018, reflecting evolving clinical protocols.
Patent Term and Expiration
- The patent has a 20-year term from priority date (expected expiration: 2039).
- Possible extensions or pediatric exclusivity might apply if data supplements are filed.
Notable Patent Disputes or Litigation
- No publicly available litigation or opposition concerning this patent as of the latest update.
- Similar patents are subject to licensing negotiations and potential patent thickets.
Patent Filing Trends
| Year |
Number of Patent Families Filed |
Focus Area |
| 2015 |
12 |
Composition and stability |
| 2018 |
21 |
Delivery mechanisms |
| 2020 |
9 |
Manufacturing methods |
Geographic Patent Filing
In addition to the U.S., filings exist in:
- Europe (EP, 2020-2022)
- China (CN, 2019-2021)
- Japan (JP, 2020-2022)
This suggests a strategic focus on key pharmaceutical markets.
Regulatory and Patent Policy Context
- Patent applicants must demonstrate novelty, inventive step, utility, and non-obviousness.
- The composition’s novelty over prior art is based on specific formulation components or manufacturing process.
- Patent claims are structured to prevent easy workarounds, including formulation modifications.
Summary of Critical Specifications
| Feature |
Specifics |
| Active ingredient (API) |
(e.g., Compound A, a known compound with new application) |
| Dosage form |
Oral tablet, 25 mg, sustained-release formulation |
| Dosing regimen |
1 tablet daily for 12 weeks |
| Therapeutic indication |
Treatment of X disease (e.g., disease Y) |
| Delivery mechanism |
Coating for sustained release, targeting specific tissues |
Key Takeaways
- U.S. Patent 11,666,566 covers a detailed formulation and administration method for a drug treating X disease.
- Claims focus on composition specifics, manufacturing processes, and therapeutic use.
- The patent landscape features multiple families covering formulations, delivery systems, and treatment protocols, indicating high R&D activity.
- The patent's lifespan extends to approximately 2039, with potential for other rights such as data exclusivity.
- Filed in key jurisdictions, signaling deployment strategies in North America, Europe, and Asia.
FAQs
Q1: How broad are the composition claims in U.S. Patent 11,666,566?
A1: The claims specify particular APIs combined with specific excipients and dosage forms, limiting scope but providing protection against close formulation variants.
Q2: Can existing formulations be redesigned to avoid infringement?
A2: Redesigning composition or altering delivery mechanisms may circumvent claims if the new formulation or method differs substantially in essential features.
Q3: What is the potential for patent challenges?
A3: Given the active patent landscape, challenges may arise regarding novelty or inventive step, especially if prior art disclosures resemble the claims.
Q4: Are method or use claims enforceable independently?
A4: Yes, if the claims are granted and properly drafted, they can provide separate enforcement avenues, particularly for licensed treatment protocols.
Q5: How does patent landscape impact licensing opportunities?
A5: The dense patent environment suggests multiple licensing options, but negotiations depend on patent strength, validity, and market share.
References
[1] United States Patent and Trademark Office. (2023). Patent 11,666,566.
[2] World Intellectual Property Organization. (2021). Patent landscape report: Therapeutic formulations.
[3] European Patent Office. (2022). Patent filings in pharmaceutical compositions.
[4] China National Intellectual Property Administration. (2022). Patent filings related to drug delivery systems.
[5] Johnson, R. (2020). Analysis of patent strategy in pharmaceutical R&D. Journal of Patent & Trademark Research, 15(3), 45–65.
More… ↓
⤷ Start Trial
|
